One year results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma

Journal of the Medical Association of Thailand

Volumn 93, Issue 2, 2010, Pages 211-214

  Thatsnarong, Duangdao ^a   Phoksunthorn, Thanon ^a   Ngamchittiampai, Chatuporn ^b  

^a Mettapracharak Hospital Nakhon Pathom   (Thailand)

^b Kratumbaen Hospital   (Thailand)

Author keywords

Primary open angle glaucoma; Selective laser trabeculoplasty

Indexed keywords

ANTIGLAUCOMA AGENT; BRIMONIDINE;

ADULT; ANTERIOR CHAMBER REACTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVAL INJECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE DISEASE; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RADIATION SAFETY; SELECTIVE LASER TRABECULOPLASTY; THERAPY EFFECT; TRABECULAR MESHWORK; TRABECULOPLASTY;

FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER THERAPY; LASERS, SOLID-STATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 77949732321     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma. A pilot study. Arch Ophthalmol 1979; 97: 319-22.
2. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 2001; 108: 773-9.
3. Van Buskirk EM. Pathophysiology of laser trabeculoplasty. Surv Ophthalmol 1989; 33: 264-72.
4. Starita RJ, Rodrigues MM, Fellman RL, Spaeth GL. Histopathologic verification of position of laser burns in argon laser trabeculoplasty. Ophthalmic Surg 1984; 15: 854-8.
5. Van Buskirk EM, Pond V, Rosenquist RC, Acott TS. Argon laser trabeculoplasty. Studies of mechanism of action. Ophthalmology 1984; 91: 1005-10.
6. Noecker RJ, Kramer TR, Latina M, Marcellino G. Comparison of acute morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty by electron microscopic evaluation [ARVO abstract]. Invest Ophthalmol Vis Sci 1998; 39: S472.
7. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995; 60: 359-71.
8. Gracner T, Pahor D, Gracner B. Efficacy of selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Klin Monbl Augenheilkd 2003; 220: 848-52.
9. Cvenkel B. One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma. Ophthalmologica 2004; 218: 20-5.
10. Geyer O, Wolf A, Levinger E, Orev T, Segev E. Selective laser trabeculoplasty treatment for medication-refractory open angle glaucoma. Harefuah 2005; 144: 790-3.
11. Weinand FS, Althen F. Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Eur J Ophthalmol 2006; 16: 100-4.
12. Gracner T, Falez M, Gracner B, Pahor D. Long-term follow-up of selective laser trabeculoplasty in primary open-angle glaucoma. Klin Monatsbl Augenheilkd 2006; 223: 743-7.
13. Qian SH, Sun XH. Selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Zhonghua Yi Xue Za Zhi 2007; 87: 118-20.
14. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, Matilla M, Macias JM, Benitez-del-Castillo JM, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye (Lond) 2004; 18: 498-502.